a b s t r a c t RNA editing was first discovered in mitochondrial RNA molecular. However, whether adenosine-toinosine (A-to-I) RNA editing has functions in nuclear genes involved in mitochondria remains elusive. Here, we retrieved 707,246 A-to-I RNA editing sites in Macaca mulatta leveraging massive transcriptomes of 30 different tissues and genomes of nine tissues, together with the reported data, and found that A-to-I RNA editing occurred frequently in nuclear genes that have functions in mitochondria. The mitochondrial structure, the level of ATP production, and the expression of some key genes involved in mitochondrial function were dysregulated after knocking down the expression of ADAR1 and ADAR2, the key genes encoding the enzyme responsible for RNA editing. When investigating dynamic changes of RNA editing during brain development, an amino-acid-changing RNA editing site (I234/V) in MFN1, a mediator of mitochondrial fusion, was identified to be significantly correlated with age, and could influence the function of MFN1. When studying transcriptomes of brain disorder, we found that dysregulated RNA editing sites in autism were also enriched within genes having mitochondrial functions. These data indicated that RNA editing had a significant function in mitochondria via their influence on nuclear genes.
Introduction
Adenosine-to-inosine (A-to-I) RNA editing is a widespread phenomenon in animals whose consequences include an increased level of transcriptome diversity [1] [2] [3] . It is a catalytic post-or cotranscriptional modification of nucleotide from adenosine to inosine in RNA carried out by the adenosine deaminase acting on the RNA (ADAR) family of enzymes [1] [2] [3] . Studies of the ADAR family indicate that adenosine-to-inosine (A-to-I) RNA editing has crucial and broad functions. For example, mammals carry three members of the ADAR family: ADAR1 and ADAR2, and ADAR3 (also known as ADAR, ADARB1, and ADARB2, respectively) [2] . In mouse, Adar1 À/À embryos die between E11.5 and E12.5 as a result of failure to maintain hematopoiesis [4] . Adar2 À/À mice develop epileptic seizures and die a few weeks after birth [5] . In Drosophila melanogaster, ADAR knock out leads to uncoordinated locomotion, temperature-sensitive paralysis, and age-dependent neurodegeneration [6] . In Caenorhabditis elegans, ADARs including ADR1 and ADR2 are essential for normal behavior, and deletion of the genes induces defective chemotaxis [7] . The most important impact of A-to-I RNA editing pertains to the nervous system [3, [8] [9] [10] . Dysregulation of RNA editing can induce a variety of diseases of the nervous system [11] [12] [13] [14] . For example, the editing level of the glutamate receptor GluA2 Q/R site might be altered in epilepsy, amyotrophic lateral sclerosis, malignant glioma, schizophrenia, and ischemia [3, 11] . Dysregulated 5-HT2CR mRNA editing might be involved in depression and suicide, schizophrenia, Prader-Willi syndrome, and metabolic diseases such as obesity and diabetes [3, 15] . Additionally, several recent studies have revealed dysregulation of A-to-I RNA editing in many tumors, and some editing sites play a role in tumorigenesis [16- 20 ]. Furthermore, A-to-I RNA editing has also been reported to have important effects on the innate immunity [21] [22] [23] .
Accumulating experiments support broad and important functions of RNA editing. It is acknowledged that RNA editing was first discovered in mitochondrial RNA molecules [24] , and mitochondrial C-to-U RNA editing has been observed in plants [25] , heteroloboseans [26, 27] and metazoans [28, 29] . We hypothesized that A-to-I RNA editing might also have a function in mitochondria. In the present study, we constructed the primate editome of Macaca mulatta. We focused on nuclear genes involved in mitochondrial functions that are subject to A-to-I editing, and characterized the functions of RNA editing in mitochondria by influencing nuclear genes involved in mitochondrial function.
Materials and methods

Ethics statement
The handling the rhesus macaque used in this study followed the guidelines and regulations of Kunming Institute of Zoology (KIZ) on animal experimentation and was approved by the Institutional Animal Care and Use Committee of the KIZ.
Genome and transcriptome generated in this study
The genomes from nine different tissues, and unstranded transcriptomes of 30 different tissues from a 25 years old rhesus macaque were sequenced by Illumina Hiseq platform. In total, 2.76 billion DNA reads and 2.20 billion RNA reads were generated, which were used to call RNA editing sites in rhesus macaque.
RNA editome in the rhesus macaque
RNA reads from different tissues were pooled together to call RNA variants based on our previously published pipeline (Fig. S1 ) [30] . Many quality control steps were performed to filter potential false-positive sites (Fig. S1 ), modified from previous pipelines [30] [31] [32] . Human editing sites were downloaded from the RADAR database (http://rnaedit.com/) [33] , and our previous study [30] . We used the LiftOver program from UCSC Genome Browser (https://genome.ucsc.edu/) to convert genomic positions between human and rhesus macaque. The editing sites shared between human and rhesus macaque were deemed as conserved editing sites. RNA editing level was calculated as the proportion of edited reads out of all mapped reads at a given site.
Transcriptomic data of rhesus macaque from other studies
In order to study the dynamic pattern of editing level in different biological processes, many transcriptomes from different projects were downloaded from previous studies [34] [35] [36] . Detailed information about generation of the transcriptome data can be found in the original publications. In brief, transcriptomic data of prefrontal cortex from 39 male macaques, with age range from À56 day to 21 years 8 days (minus indicate days before birth) were retrieved from a previous study by He et al. [34] . Transcriptome data from different tissues including brain, colon, heart, kidney, liver, lung, skeletal muscle, spleen, and testes were taken from a previous study by Merkin et al. [35] . Transcriptomic data during differentiation of embryonic stem cells into neural stem cells were taken from a previous study by Zhao and coworkers [36] .
RNA editing in brain disorder
The prefrontal cortex transcriptomes of 34 autism cases (2-60 years old) and 40 controls (0-62 years old), sequenced by RNA-sequencing were taken from a previous study by Liu and coworkers [37] . Detailed information about sampling and sequencing can be found in the original publication. Human editing sites were downloaded from the RADAR database (http://rnaedit.com/) [33] and our previous study [30] . Editing level of each site within each tissue was calculated, and tissues containing reads covering the sites lower than 5 were discarded. Significance of differential RNA level between case and control was calculated by the generalized linear models function in R, adjusted for age, sex and gene expression value.
ADAR gene knock-down experiments
U251 glioma cells were introduced from the Kunming Cell Bank, KIZ, and were cultured in Roswell RPMI-1640 medium (HyClone, Logan, UT) supplemented with 10% fetal bovine serum, 100 U/mL penicillin and 100 g/mL streptomycin in 5% CO 2 at 37°C. Transfection with siRNA was performed using an electroporator (CUY21EDIT, Nepa gene, Japan). After electroporation, cells were seeded in normal growth medium for 48 h and then used in experiments. Appropriately same amount of treated cells were washed once with 1X PBS followed by addition of lysis buffer (Beyotime, China) at 4°C for 30 min. After centrifugation at 12,000 g for 15 min, the supernatant was collected. Proteins (25 lg) were separated on 12% (w/v) SDS-polyacrylamide gels and transferred to a polyvinylidene difluoride membrane (Roche, USA) using a BioRad semi-dry transfer apparatus. The membrane was soaked with 5% (w/v) skim milk for 2 h at room temperature and then incubated with primary antibodies against ADAR1 (Merck Millipore, MABE888; 1:1000), ADAR2 (Merck Millipore, MABE889; 1:1000), Mfn1 (Abcam Inc., ab57602, 1:1000), TIM23 (Proteintech , and GAPDH (Proteintech, 60004-I-IG; 1:20,000) overnight at 4°C. After three washes with TBST (each wash 5 min), the membrane was incubated with anti-mouse or anti-rabbit IgG peroxidase-conjugated secondary antibody (KPL, Gaithersburg, MD, USA) (1:10,000) for 1 h at room temperature. Immobilon Western Chemiluminescent HRP Substrate (Millipore, USA) was used to visualize the epitope.
Confocal fluorescence microscopy
Confocal fluorescence microscopy was used to investigate the expression levels of ADAR1 or ADAR2 and mitochondrial morphology. After electroporation with siRNA 48 h, U251 cells were incubated with 50 nmol/L MitoTracker (Life Technologies; M7512; USA) washed thrice with 1X PBS and then fixed with paraformaldehyde (PFA; 4% (w/v)) in phosphate-buffered saline (PBS) for 10 min. The cells were then permeabilized using 0.2% (v/v) Triton X-100, followed by a block in 5% (w/v) bovine serum albumin 1 h at room temperature. Cells were incubated with primary antibody (anti-ADAR1 or anti-ADAR2) overnight at 4°C, then with a FITC-conjugated secondary antibody (KPL, 1:50) for 1 h at room temperature after three washes with PBS. 4 0 ,6-Diamidino-2 -phenylindole (DAPI) (Roche, USA) was used to color the nucleus. Cells imaging was done using the Olympus FluoView TM 1000 confocal microscope (Olympus, Melville, NY, USA) at 488 and 563 nm, respectively.
Measurement of mitochondrial mass level
For mitochondrial mass measurement, U251 cells were harvested 72 h after transfection with the indicated siRNA, and then incubated in prewarm medium with 100 nmol/L MitoTracker Red FM (Molecular Probe, USA, M22425) at 37°C for 30 min, then washed with prewarmed PBS and analyzed by using flow cytometry (BD) at 644 nm.
Determination of cellular ATP level
U251 cells were seeded in 12-well plates after transfection with the indicated siRNA. Forty-eight hours later, cells were lysed in 100 lL lysis buffer (GENMED, China, GMS10050). 10 lL of cell lysate was used to measure cellular ATP level per the manufacture's manual for ATP Determination Kit (Invitrogen) on a GloMax 96 Luminometer (Promega). The final ATP value was normalized to the protein concentration of each sample.
Functional characterization of MFN1 I234/V
The pcDNA3.1/myc-His(À) A plasmid (Invitrogen, CA, USA) was used to construct the expression plasmid. This plasmid was digested with XhoI and KpnI to prepare the cloning vector. For insert preparation, PCR was performed to obtain the full-length MFN1 cDNA using the forward primer 5 0 -ATGCTGTGGGA TAAAGTTCTCCCTA-3 0 and reverse primer 5 0 -GGATTCTTCATTGCTT GAAGGTAGAA-3 0 . Subsequently, PCR was performed to attach the tag using forward primer 5 0 -CTCGAGGAGCAGAAACTCATCTCTGAA GAGGATCTGGAGCAGAAACTCATCTCTGAAGAGGATCTGGAGCAGAA ACTCATCTCTGAAGAGGATCTGGAGCAGAAACTCATCTCTGAAGAGGA TCTGGAGCAGAAACTCATCTCTGAAGAGGATCTGGAGCAGAAACTCAT CTCTGAAGAGGATCTGATGCTGTGGGATAAAGTTCTC-3 0 (XhoI and 6Âmyc tag attached) and reverse primer 5 0 -GGTACCCTTATCGTCGT CATCCTTGTAATCCTTATCGTCGTCATCCTTGTAATCCTTATCGTCGTCA TCCTTGTAATCCTTATCGTCGTCATCCTTGTAATCCTTATCGTCGTCATC CTTGTAATCCTTATCGTCGTCATCCTTGTAATCGGATTCTTCATTGCTTG AAGG (KpnI site and 6ÂFLAG tag attached). The products were then digested with XhoI and KpnI and cloned into the prepared vector to generate the pcDNA3-MFN1 plasmid. The MFN1 RNA editing fragment was produced by PCR using the pcDNA3-MFN1 plasmid as a template by a PCR-based approach, and similar steps as stated above were used to generate the pcDNA3-MFN1(I234/V) plasmid.
The human glioblastoma T98G cell line was provided by the American Type Culture Collection (ATCC; Rockville, MD, USA) and maintained in Modified Eagle's Medium (MEM, Thermo, Beijing, China) supplemented with 10% fetal bovine serum (FBS), 1% penicillin, and streptomycin (Invitrogen, Beijing, China). The constructed plasmids were transfected into T98G cells using X-tremeGENE HP DNA transfection reagent following the manufacturer's manual (Roche, Mannheim, Germany). The T98G cells transfected with pcDNA3-MFN1 or pcDNA3-MFN1 (I234/V) plasmids were dissolved in radioimmunoprecipitation assay (RIPA) buffer (Pierce, IL, USA) with the addition of EDTA-free protease inhibitor Cocktail Tablets (Roche, Mannheim, Germany). Protein concentration in the supernatant was determined by the bicinchoninic acid (BCA) protein assay kit (Thermo, IL, USA). The cell lysate was subjected to SDS-PAGE and transferred onto polyvinylidene fluoride (PVDF) membranes (Millipore, MA, USA). The membranes were incubated with anti-myc antibody (1:1000, Clontech, Mountain Valley, CA), anti-FLAG monoclonal antibody (1:1000, Sigma, MO, USA), or anti-actin monoclonal antibody (1:1000, Cell Signaling Technology, MA, USA) and subsequently incubated with horseradish peroxidase-conjugated secondary antibody (1:5000, Santa Cruz Biotechnology Inc. California, USA). Immunoreactive bands were visualized by SuperSignalWest Pico Chemiluminescent Substrate (Thermo, IL, USA) using an Amersham Imager 600 (GE, Tokyo, Japan).
Cell viability and apoptosis assays
Cell viability was measured by the Sulforhodamine B (SRB, Sigma, St. Louis, MO) assay per a previous report [38] . In brief, T98G cells were seeded into 12-well plates and then transfected after 24 h. After transfection for 0, 24, 48, and 72 h, the cells were fixed and washed. Finally, Tris-base buffer was added to each well, and optical densities at 530 nm were measured by a spectrophotometric plate reader. Cell apoptosis was analyzed using Caspase-3 Colorimetric Assay (RD Pharmingen, San Diego, CA) per the company's protocol. Briefly, T98G cells were transfected with pcDNA3-MFN1or pcDNA3-MFN1(I234/V). After transfection for 48 h, the control and experimental cells were harvested, mixed with 50 lL of cell lysis buffer and kept on ice for 10 min. Subsequently, 50 lL of 2x Reaction Buffer 3, containing 10 mmol/L DTT and 5 lL of caspase-3 colorimetric substrate (DEVD-pNA), were added to each of the supernatant cytosolic extracts. After a 1.5 h incubation at 37°C, the absorbance of samples was measured at 405 nm.
Results
Evaluating the influence of sequence coverage on RNA editing calling
In the study by Chen et al. [39] , only 31,250 A-to-I RNA-editing sites were identified in rhesus macaque [39] , much fewer compared to human containing millions of editing sites [3, 30] . In the present study, we firstly constructed an exhaustive editome of primate to facilitate the investigation of function of A-to-I RNA editing.
As A-to-I RNA editing is prominent in nervous system, we reason that more data from more different brain structures will undoubtedly facilitate the detection of RNA editing in the primate. In addition, many somatic mutations identified in different tissues (Table S1 ) could cause false positive, which has not been considered in the previous studies. Accordingly, to build a comprehensive editome of the rhesus macaque, more than 1.96 billion reads from 30 tissue samples (including 21 tissues from different brain structures) from a 25 years old rhesus macaque were generated by deep RNA sequencing (Table S2) , and another nine genomes from nine different tissues of the same donor were sequenced with more than 80X depth (Table S1 ). We leveraged a pipeline modified from previous studies [30, 31] , to separately call RNA editing sites at Alu and non-Alu regions in the genome of the rhesus macaque based on transcriptomic and genomic data (Fig. S1 ). Mapped RNA reads from all tissues were pooled to increase the sequence coverage for calling RNA-DNA difference sites (RDDs) (Fig. S1 ), whereas DNA mapped reads from the same individual were used to filter out sites of DNA mutations.
We firstly evaluated the influence of sequence coverage of the transcriptome on the number of identified editing sites [31, 40] based on randomly selected reads. More A-to-G/T-to-C RDDs were called in both Alu and non-Alu regions when more reads were used, as previously reported in humans [41] , whereas other types of RDDs were negligible (Fig. 1a, b) . The proportion of A-to-G/Tto-C RDDs was very high in the Alu region and increased rapidly in the non-Alu region when more reads were used for the analysis (Fig. 1c) , indicating that more RNA reads would generate a more accurate and exhaustive RNA editome, particularly for editing in the non-Alu region.
Next, we investigated the influence of sequencing coverage on the editing sites at different genomic regions. More A-to-G/T-to-C RDDs were called in intronic and exonic regions when more reads were used (Fig. 1d, e) . In contrast, in the 3 0 -UTR (untranslated region), only $300 sites could be called with at least 200 million reads (Fig. 1f) . The small number of editing sites detected in the 3 0 -UTR is incompatible with previous finding of many editing sites located in the 3 0 -UTR [42, 43] , which may be attributable to the low quality of UTR annotation in rhesus macaques due to limitations of bioinformatic methods in gene annotation with little transcriptome data. Similarly, in the 5 0 -UTR region, very few editing sites could be identified, but no significant increase was found when more reads were used (Fig. 1g) . The ratios of other type of RDDs were comparatively lower in intronic and 3 0 -UTR regions but were relatively higher in exonic and 5 0 -UTR regions ( Fig. 1d-g ). The observation suggested that it is necessary to use large-scale sequenced RNA reads to accurately call RNA editing events in exonic and 5 0 -UTR regions.
A-to-I RNA editome of rhesus macaque
Considering that more transcriptomic data will be helpful to improve the identification of RNA editing sites, we used all transcriptomic data to identify RNA editing sites. With respect to the high false-positive rate of other types of RNA editing [44] , we only considered A-to-I (G) RNA editing, which were A-to-G/T-to-C RDDs. A total of 707,246 A-to-I RNA editing sites were identified in the rhesus macaque (Fig. 2a, b) . A high percentage of A-to-I RNA editing among all RDDs types (98.62%) implies that our method had a low false-discovery rate. To further confirm the accuracy of our datasets, we randomly chose 16 sites for validation by Sanger sequencing, and all of these sites turned out to be true (Fig. S2) . Compared with the previous study, which identified only 31,250 RNA-editing sites [39] , the number of editing sites detected in our study was unprecedented, likely due to the different filtering strategies employed, and more samples (30 samples including 21 from brain in this study versus 7 samples including 2 from brain from Ref. [39] ), and large data size (1.96 billion reads in this study versus 824.8 millions reads in Ref. [39] ).
A total of 310,888 A-to-I RNA editing sites within gene regions were used for the following analyses. Only 98,545 RNA editing sites were conserved between humans and rhesus macaques, highlighting rapid origin of RNA editing during evolution. As expected, conserved RNA editing sites displayed higher levels of RNA editing than nonconserved RNA editing and thus may possess more important functions (Fig. 2d) . Editing level of each tissue was calculated as the average editing level of all RNA editing sites in the tissue. Comparison among different tissues revealed that the level of RNA editing was most pronounced in the brain, while testis harbored the lowest level of RNA editing ( Fig. 2c and d) .
When comparing editing levels among different tissues, we found that editing level were positively correlated with expression levels of ADAR1 and ADAR2, but not ADAR3, among different tissues (P < 0.05, by Pearson correlation analysis, Fig. 3a-c) . Editing level didn't exhibit correlation with sequence coverage (Fig. 3d) . We sought to identify the sites where editing level was correlated with expression values of ADAR genes. However, the editing levels of only 1483, 1873, and 1498 sites were correlated with ADAR1, ADAR2, or ADAR3 mRNA expression, respectively (Fig. S3a) . This suggests that editing levels of many RNA editing sites in a tissue may not be dependent only on the mRNA expression of ADAR genes. Some other factors, like the splicing machinery, which also targets RNA, might influence double-stranded RNA strength and shape, and the editing level [30] .
Annotation of these sites with editing levels correlating with mRNA expression of ADAR1, ADAR2, or ADAR3 identified 756, 861, and 754 genes, respectively (Fig. S3b) . Gene enrichment analyses of these genes showed that the categories associated with mitochondria were over-represented (Table S3 ). The finding indicated that many genes having function in mitochondria could be influenced by the ADAR genes. Inspired by the finding, we next investigated function of A-to-I RNA editing in nuclear genes involved in mitochondria.
Knock-down of ADAR affects mitochondria
To explore potential function of A-to-I RNA editing in mitochondria, we firstly depleted endogenous ADAR1 or ADAR2 expression in human glioma cell line U251 by RNA interference (Fig. 4, Fig. S4 ). The reduced protein expression levels of ADAR1 or ADAR2 were well confirmed with antibody. Cells transfected with negative control siRNA (scramble) and ADAR1 siRNAs retained the normal tubular spiral mitochondrial network (Fig. S4a) . In contrast, the mitochondria in cells transfected with ADAR2 siRNAs frequently exhibited a highly interconnected, fibrous, and more elongated form (Fig. 4a) . We further assessed the influence of knock down of ADAR1 and ADAR2 on the protein expression levels of ATP5A, TIM23, TOM20, MFN1, and COXIV, which are the key proteins involved in mitochondrial functions. Consequently, the expression of ATP5A, TIM23, and MFN1 were upregulated upon ADAR2 siRNAs transfection (Fig. 4b-f) , and the expression of ATP5A was upregulated upon ADAR1 siRNAs transfection (Fig. S4d) . ATP5A encodes a subunit of mitochondrial ATP synthase [45] . TIM23 is part of a complex located in the inner mitochondrial membrane that mediates the transport of transit peptide-containing proteins across the membrane [46] . MFN1 is a mediator of mitochondrial fusion [47] . The altered expression levels of these mitochondrial proteins in response to ADAR2 knockdown are consistent with the notion that ADAR genes play a key role in regulating mitochondrial function.
Similarly, the level of ATP production was upregulated after knockdown of ADAR1 (Fig. S4f) and ADAR2 (Fig. 4h) . In contrast, the mitomass (mitochondrial mass) did not change (Fig. S4e,  Fig. 4g ) upon knockdown of the two ADAR genes. These experiments suggested that ADAR1 and ADAR2 have a functional impact on mitochondria and nuclear genes involved in mitochondria. The were based on transcriptome data from different tissues including brain, colon, heart, kidney, liver, lung, skeletal muscle, spleen, and testes that were taken from the study by Merkin et al. [35] .
caveat of this experiment is that ADAR might function, not dependent of its editing activity [48] . Therefore, we could not conclude whether phenotypic changes in mitochondria were attributable to changes of RNA editing or changes of gene expression induced by ADAR, although ADAR is responsible for RNA editing.
Examining dynamics of RNA editing level during early development of the brain found an amino-acid-changing RNA editing site in MFN1, a mediator of mitochondrial fusion
Previous studies found that editing levels of RNA editing sites changed during the development of the mammalian brain [49] [50] [51] [52] . Inspired by this observation, we investigated whether any RNA editing in genes involved in mitochondria might be coupled to the brain development. We leveraged transcriptomic data from the prefrontal cortex of 39 male macaques, with ages ranging from À56 days to 21 years, 8 days (minus indicates days before birth) (these data were first reported by He and coworkers [34] ), to investigate editing dynamics during brain development. Based on the macaque editome retrieved above, we found that the editing levels increased dramatically in early age, while there was no significant alteration in adulthood (Fig. 5a and c) . It corroborates that editing efficiency increases during neuronal differentiation and brain maturation [53] .
We also examined the dynamics of expression values of ADAR1, ADAR2, and ADAR3 genes, which are the three key genes encoding the enzyme responsible for A-to-I RNA editing by site-specific deamination of adenosines. The expression pattern of ADAR1 and ADAR2 mirrored the pattern of change observed in editing levels, with dramatic increases in the early stages of life (Fig. 5b, d , e), indicating that both ADAR1 and ADAR2 play important roles in brain development. In stark contrast, the expression level of ADAR3 decreased during early brain development (Fig. 5b, f) . In order to further validate the dramatic increase in RNA-editing level in early developmental stages observed in macaques, we repeated the editing dynamics analysis using human editing sites downloaded from Rigorously Annotated Database of A-to-I RNA Editing (RADAR) [33] , plus the reported brain transcriptome data from 14 male adolescents [54] . As expected, a similar pattern was found during the early stages of human brain development (Fig. S5)) .
Furthermore, we sought to identify the sites undergoing significant changes during brain development. In total, 172 sites with editing levels positively correlated with age were identified (P < 0.05), of which 162 sites were in introns, 5 in the 3 0 -UTR, and 5 in coding exons. The 172 sites were located in 102 genes, and gene enrichment analysis revealed two enriched terms: ionotropic glutamate receptor signaling pathway (gene ontology (GO): 0035235, genes ATP1A3, GRIA2, GRIA3, GRIK1) and glutamatergic synapse (KEGG: 04724) (PLA2G4C, GNB4, GRIA2, GRIA3, GRIK1) ( Table S4 , P = 8.01 Â 10 À3 ). Genes encoding the glutamate receptor channel have been reported to be regulated by editing [49, 50] . The change in editing level implies that the glutamate receptor channel may experience functional regulatory modulation during brain development.
We then focused on four editing sites that cause nonsynonymous changes in four genes: GRIK1 (Q638/R), GRIA2 (R717/G), KCNA1 (I400/V), and MFN1 (I234/V). As expected, all four sites harbored significantly higher editing levels in the brain (Fig. S6) . GRIK1 Q/R editing level has been reported to increase during the development of the rat hippocampus [50] , whereas the GRIA2 R/G editing level increased during the development of the rat embryonic brain and caused faster recovery from desensitization [49] . As for KCNA1 I/V, the editing was located in the porelining S6 domain of Shaker-type K + channels [9] .
While MFN1 is known to be a mediator of mitochondrial fusion [47] , no study has reported the functional consequence of MFN1 I234/V. Therefore, in this study, we first validated the editing site I234/V by Sanger sequencing (Fig. 6a) . Then, guided by the findings from a previous study revealing that phosphorylation of MFN1 by ERK could regulate cell death and apoptosis in primary cortical neurons [55] , we tested whether RNA editing of MFN1 (I234/V) altered its function. We constructed the expression vectors of pcDNA3-MFN1 and pcDNA3-MFN1 (I234/V) and transfected them into the human glioblastoma T98G cell line (Fig. 6b) . The overexpression of unedited MFN1 and edited MFN1 proteins was confirmed by using both anti-myc (N-terminal tag) and anti-Flag (Cterminal tag) antibodies (Fig. 6c) . Cell growth of unedited MFN1 and edited MFN1 (I234/V) overexpression was determined in T98G cells by the sulforhodamine B (SRB) assay [38] . The overex- pression of MFN1 dramatically increased cell proliferation at 48 h and 72 h after transfection. However, overexpression of edited MFN1 (I234/V) significantly suppressed cell proliferation compared with unedited MFN1 overexpression at 48 h (P < 0.001) and 72 h (P < 0.001) (Fig. 6d) . In addition, overexpression of unedited MFN1 significantly suppressed apoptosis compared with empty vector (P < 0.001), but I234/V editing resulted a decrease in suppressing apoptosis (P < 0.001) (Fig. 6e) . These results suggest that MFN1 I234/V editing has a functional consequence.
Examining brain disorder found dys-regulation of RNA editing in nuclear genes involved in mitochondria in autism
The most important impact of A-to-I RNA editing pertains to the nervous system [3, [8] [9] [10] . Dysregulation of RNA editing can induce a variety of diseases of the nervous system [11] [12] [13] [14] . We examined whether any gene involved in mitochondria harboring dysregulated RNA editing in autism spectrum disorder (ASD), which is a group of clinically heterogeneous neurodevelopmental disorders characterized by the disruption of social functioning and inclination toward restricted interests and repetitive behaviors [56, 57] . By comparing the prefrontal cortex transcriptomes of 34 autism cases (2-60 y old) and 40 controls (0-62 y old) [37] , we found that expression levels of ADAR1 and ADAR2 were down-regulated in autism ( Fig. 7a , P = 0.0049 and 0.00052, respectively, based on linear model), suggesting potential change of RNA editing in autism. Totally 75 sites located within 57 genes were identified to exhibit significantly differential editing levels between autism and control (Table S5) . Gene enrichment analysis of these genes found 14 genes involved in mitochondria (Fig. 7b, Table S6 ). This finding of an association supported function of nuclear gene RNA editing in mitochondria, although more experiments were needed to validate functional consequence of these RNA editing sites.
Discussion
The rhesus macaque (Macaca mulatta), which is physiologically and anatomically close to humans and responds similarly to many diseases, provides a huge advantage over other animal models [58, 59] . It will be necessary to study some primate-specific mechanisms or diseases in the rhesus macaque because the same research in humans could not be performed due to ethical issue. There have been many studies using the rhesus macaque as an animal model to study brain evolution [34, 60] , specific virus invasion [61] , embryonic stem cells [36] (for a review, Ref [59] ). Expansion of RNA editing in primate made rhesus macaque as perfect model to study function of RNA editing. In this study, we constructed the primate editome of Macaca mulatta and characterized the functions of RNA editing in mitochondria.
RNA editing occurring in nuclear genes influence the function of mitochondria
Although RNA editing has frequently been observed in mitochondrial sequences, most frequent are C-to-U types [62] . Whether A-to-I RNA editing has functions in nuclear genes involved in mitochondria remains elusive. Here, we found that A-to-I RNA editing occurred frequently in nuclear genes that have functions in mitochondria. When knocking down the expression of ADAR1 and ADAR2, which are the key genes encoding the enzyme responsible for RNA editing, the mitochondrial structure, the level of ATP production, and the protein expression of some key genes involved in mitochondrial function, were changed. These data suggested that RNA editing might have a significant function in mitochondria via their influence on nuclear-coded mitochondrial genes.
RNA editing during early stages of brain development
After birth, neurogenesis proceeds with rapid generation of glial cells until early childhood. Brain development in the early postnatal stage is characterized by an enormous proliferation of dendrites and axons and subsequent synaptogenesis, glial proliferation, and myelination, mainly in the forebrain and cerebellum [63] . From late childhood to adolescence, considerable structural modifications and molecular reorganization of neural circuits continue, although in a less dramatic fashion compared with the initial prenatal and early postnatal stages. These later developmental changes coincide with the emergence of higher-order cognition and complex behavior [63] . Although the causal relationship between a dramatic increase in the level of RNA editing and brain development is unclear, evidence suggests that RNA editing might be key in neurogenesis, and as neurogenesis proceeds, RNA editing levels consequently increase [53] . Indeed, the editing level increased during the process of differentiation of embryonic stem cells to neural stem cells (Fig. S7) . Our analysis for the dynamics of RNA editing level during early development of the brain identified an amino-acid-changing RNA editing site in MFN1, a well known mediator of mitochondrial fusion [47] . Further functional assays at the cellular level, using this particular case, showed the RNA editing site in MFN1 affected cell proliferation and apoptosis (Fig. 7) , which provided evidence to support an active role of RNA editing in brain development. In conclusion, our extensive investigation of primate editome supported that A-to-I RNA editing had a role in mitochondria by influencing nuclear genes involved in the function of mitochondria based on the following lines of evidences: (1) frequent occurrence of RNA editing in many nuclear genes involved in mitochondria; (2) RNA editing site in MFN1, a mediator of mitochondrial fusion, is associated with brain development; (3) dys-regulation of RNA editing in nuclear genes involved in mitochondria in autism; (4) knock-down of ADAR affects mitochondrial phenotypes. These data will lay a basis for further characterization of RNA editing pattern in brain development and brain diseases.
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